Reporting owner · CIK 0001380710

Davis George Eric

Visual SEC Form 4 history across 1 companies, 12 transactions and 5 filings.

EVP, CLOEVP, Chief Legal OfficerBIOMARIN PHARMACEUTICAL INC
Open-market mix
Latest filingSep 03, 2026, 10:41 PM
Filings5Form 4 records
Buying$00 purchases
Selling$2.8M2 sales
Net value−$2.8MBuys minus sells
Companies12 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 251Feb 26Mar 261Sep 26

Net value flow

Buys minus sells

Feb 25
$0
Feb 26
−$1.6M
Mar 26
$0
Sep 26
−$1.2M

Transaction texture

Ownership and ticket size

Average P/S size$1.4M
Median P/S size$1.4M
Direct12
Indirect0
Sep 02, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context1Direct Ownershipfiling-context11Large Holdings Increaseholdings1Large Holdings Reductionholdings1Large Salesize1

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at BIOMARIN PHARMACEUTICAL INC on Sep 02, 2026 valued at $1,163,748.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at BIOMARIN PHARMACEUTICAL INC on Sep 02, 2026 valued at $1,163,748.

Review SEC filing

Associated companies

Visual map of known reporting history

BMRNBIOMARIN PHARMACEUTICAL INC12 transactions · latest Sep 03, 2026, 10:41 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
BMRNDavis George Eric
EVPCLO
sale17.5k-$116MS
Direct Ownership Large Holdings Reduction Large Sale
0.0%09/0309/02
BMRNDavis George Eric
EVPCLO
withholding1.27k-$7.13MF
Direct Ownership
−0.0%03/1903/18
BMRNDavis George Eric
EVPCLO
grant34.6k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
−0.7%03/1703/16
BMRNDavis George Eric
EVPCLO
grant14.5k$0A
Direct Ownership
−0.7%03/1703/16
BMRNDavis George Eric
EVPCLO
withholding7.17k-$41.9MF
Direct Ownership
−0.7%03/1703/16
BMRNDavis George Eric
EVPCLO
sale26.0k-$159MS
Direct Ownership Large Holdings Reduction Large Sale
−14.3%02/2602/26
BMRNDavis George Eric
EVPCLO
grant2.37k$0A
Direct Ownership
−14.3%02/2602/25
BMRNDavis George Eric
EVPCLO
grant6.67k$0A
Direct Ownership
−14.3%02/2602/25
BMRNDavis George Eric
EVPCLO
grant6.17k$0A
Direct Ownership
−14.3%02/2602/25
BMRNDavis George Eric
EVPCLO
grant9.36k$0A
Direct Ownership
—02/28/202502/25/2025

Davis George Eric Insider Activity FAQ

SEC Form 4 context

Who is Davis George Eric?

Davis George Eric is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001380710.

Which companies has Davis George Eric reported transactions for?

BIOMARIN PHARMACEUTICAL INC

When was Davis George Eric's latest insider buy?

No open-market insider purchase is available for this period.

When was Davis George Eric's latest insider sale?

sale at BIOMARIN PHARMACEUTICAL INC on Sep 02, 2026 valued at $1,163,748.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.